Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing.

Nature communications - 10 Nov 2020

Lang Guan-Tian, Jiang Yi-Zhou, Shi Jin-Xiu, Yang Fan, Li Xiao-Guang, Pei Yu-Chen, Zhang Chen-Hui, Ma Ding, Xiao Yi, Hu Peng-Chen, Wang Hai, Yang Yun-Song, Guo Lin-Wei, Lu Xun-Xi, Xue Meng-Zhu, Wang Peng, Cao A-Yong, Ling Hong, Wang Zhong-Hua, Yu Ke-Da, Di Gen-Hong, Li Da-Qiang, Wang Yun-Jin, Yu Ying, Shi Le-Ming, Hu Xin, Huang Wei, Shao Zhi-Ming

Abstract excerpt

The remarkable advances in next-generation sequencing technology have enabled the wide usage of sequencing as a clinical tool. To promote the advance of precision oncology for breast cancer in China, here we report a large-scale prospective clinical sequencing program using the Fudan-BC panel, and comprehensively analyze the clinical and genomic characteristics of Chinese breast cancer. The mutational landscape...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Molecular Targeted Therapy

Share to Neurofibromin 2

Share to Oncogenes

Share to Precision Medicine

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 33173047
DOI: 10.1038/s41467-020-19342-3
PMCID: PMC7656255

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing.PMID 33173047Read ↗

Targeted gene next-generation sequencing reveals genomic profile in a cohort of 46 Chinese patients with breast cancer.Semantic proximity Read ↗

The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.Semantic proximity Read ↗

Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilitiesSemantic proximity Read ↗

Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigmsSemantic proximity Read ↗

Age-related genomic characterization and therapeutic targets in Chinese breast cancer: insights from prospective targeted sequencing and clinical data analysis.Semantic proximity Read ↗

Clinical Genomic Profiling to Identify Actionable Alterations for Very Early Relapsed Triple-Negative Breast Cancer Patients in the Chinese PopulationSemantic proximity Read ↗

Germline Variants in 32 Cancer-Related Genes among 700 Chinese Breast Cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study.Semantic proximity Read ↗

Comprehensive molecular profiling broadens treatment options for breast cancer patients.Semantic proximity Read ↗

Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.Semantic proximity Read ↗

Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancerSemantic proximity Read ↗

Prevalence and Spectrum of BRCA1/2 Germline Mutations in Women with Breast Cancer in China Based on Next-Generation Sequencing.Semantic proximity Read ↗

Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analysesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.